1. Home
  2. TTEC vs ANIX Comparison

TTEC vs ANIX Comparison

Compare TTEC & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TTEC Holdings Inc.

TTEC

TTEC Holdings Inc.

HOLD

Current Price

$2.45

Market Cap

107.8M

Sector

Technology

ML Signal

HOLD

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

HOLD

Current Price

$2.61

Market Cap

104.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TTEC
ANIX
Founded
1982
1982
Country
United States
United States
Employees
69400
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
107.8M
104.0M
IPO Year
1996
2013

Fundamental Metrics

Financial Performance
Metric
TTEC
ANIX
Price
$2.45
$2.61
Analyst Decision
Hold
Strong Buy
Analyst Count
2
3
Target Price
N/A
$8.67
AVG Volume (30 Days)
643.6K
88.6K
Earning Date
05-07-2026
03-09-2026
Dividend Yield
N/A
N/A
EPS Growth
40.80
12.82
EPS
N/A
N/A
Revenue
$1,509,171,000.00
$210,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$0.10
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.15
N/A
52 Week Low
$1.98
$2.33
52 Week High
$5.60
$5.46

Technical Indicators

Market Signals
Indicator
TTEC
ANIX
Relative Strength Index (RSI) 45.37 42.17
Support Level $2.09 N/A
Resistance Level $3.91 $3.10
Average True Range (ATR) 0.20 0.20
MACD -0.02 -0.00
Stochastic Oscillator 20.61 30.00

Price Performance

Historical Comparison
TTEC
ANIX

About TTEC TTEC Holdings Inc.

TTEC Holdings Inc provides customer engagement management tools and services. The company operates through two operating segment, TTEC Digital and TTEC Engage. TTEC Digital is engaged in building and implementing cloud-based and on-premises customer experience tools that enable clients to develop customer engagement strategies. TTEC Engage focuses on delivering sales and marketing solutions to help clients boost their revenue as well as on managing customer's front-to-back office processes to optimize the customer experience. TTEC Engage contributes the vast majority of the company's revenue, and its revenues are derived from the United States and Canada, followed by Philippines, Asia-Pacific and India.

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.

Share on Social Networks: